Myomo Inc. found using ticker (MYO) have now 4 analysts covering the stock with the consensus suggesting a rating of ‘Buy’. The range between the high target price and low target price is between 23 and 6.7 calculating the mean target price we have 11.68. Given that the stocks previous close was at 1.82 this would indicate that there is a potential upside of 541.8%. There is a 50 day moving average of 1.78 and the 200 day MA is 4.55. The company has a market capitalisation of $13m. Visit the company website at: https://www.myomo.com
The potential market cap would be $81m based on the market concensus.
Myomo, a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient’s weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, and rehabilitation hospitals, as well as through distributors. Myomo was incorporated in 2004 and is headquartered in Boston, Massachusetts.
